Use of Ecological Momentary Assessment Through a Passive Smartphone-Based App (eB2) by Patients With Schizophrenia: Acceptability Study

Javier-David Lopez-Morinigo, María Luisa Barrigón, Alejandro Porras-Segovia, Verónica González Ruiz-Ruano, Adela Sánchez Escribano Martínez, Paula Jhoana Escobedo-Aedo, Sergio Sánchez Alonso, Laura Mata Iturralde, Laura Muñoz Lorenzo, Antonio Artés-Rodríguez, Anthony S David, Enrique Baca-García, Javier-David Lopez-Morinigo, María Luisa Barrigón, Alejandro Porras-Segovia, Verónica González Ruiz-Ruano, Adela Sánchez Escribano Martínez, Paula Jhoana Escobedo-Aedo, Sergio Sánchez Alonso, Laura Mata Iturralde, Laura Muñoz Lorenzo, Antonio Artés-Rodríguez, Anthony S David, Enrique Baca-García

Abstract

Background: Ecological momentary assessment (EMA) tools appear to be useful interventions for collecting real-time data on patients' behavior and functioning. However, concerns have been voiced regarding the acceptability of EMA among patients with schizophrenia and the factors influencing EMA acceptability.

Objective: The aim of this study was to investigate the acceptability of a passive smartphone-based EMA app, evidence-based behavior (eB2), among patients with schizophrenia spectrum disorders and the putative variables underlying their acceptance.

Methods: The participants in this study were from an ongoing randomized controlled trial (RCT) of metacognitive training, consisting of outpatients with schizophrenia spectrum disorders (F20-29 of 10th revision of the International Statistical Classification of Diseases and Related Health Problems), aged 18-64 years, none of whom received any financial compensation. Those who consented to installation of the eB2 app (users) were compared with those who did not (nonusers) in sociodemographic, clinical, premorbid adjustment, neurocognitive, psychopathological, insight, and metacognitive variables. A multivariable binary logistic regression tested the influence of the above (independent) variables on "being user versus nonuser" (acceptability), which was the main outcome measure.

Results: Out of the 77 RCT participants, 24 (31%) consented to installing eB2, which remained installed till the end of the study (median follow-up 14.50 weeks) in 14 participants (70%). Users were younger and had a higher education level, better premorbid adjustment, better executive function (according to the Trail Making Test), and higher cognitive insight levels (measured with the Beck Cognitive Insight Scale) than nonusers (univariate analyses) although only age (OR 0.93, 95% CI 0.86-0.99; P=.048) and early adolescence premorbid adjustment (OR 0.75, 95% CI 0.61-0.93; P=.01) survived the multivariable regression model, thus predicting eB2 acceptability.

Conclusions: Acceptability of a passive smartphone-based EMA app among participants with schizophrenia spectrum disorders in this RCT where no participant received financial compensation was, as expected, relatively low, and linked with being young and good premorbid adjustment. Further research should examine how to increase EMA acceptability in patients with schizophrenia spectrum disorders, in particular, older participants and those with poor premorbid adjustment.

Trial registration: ClinicalTrials.gov NCT04104347; https://ichgcp.net/clinical-trials-registry/NCT04104347.

Keywords: acceptability; digital health; digital tools; eB2; ecological momentary assessment; internet; mental health; mobile apps; patients; real-time data; schizophrenia; schizophrenia spectrum disorders.

Conflict of interest statement

Conflicts of Interest: AAR and EBG cofounded the evidence-based behavior app.

©Javier-David Lopez-Morinigo, María Luisa Barrigón, Alejandro Porras-Segovia, Verónica González Ruiz-Ruano, Adela Sánchez Escribano Martínez, Paula Jhoana Escobedo-Aedo, Sergio Sánchez Alonso, Laura Mata Iturralde, Laura Muñoz Lorenzo, Antonio Artés-Rodríguez, Anthony S David, Enrique Baca-García. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 26.07.2021.

Figures

Figure 1
Figure 1
Flowchart in this study. eB2: evidence-based behavior.

References

    1. Measuring digital development: Facts and figures 2020. International Telecommunication Union. [2020-11-12]. .
    1. Barrigón María Luisa, Berrouiguet S, Carballo JJ, Bonal-Giménez Covadonga, Fernández-Navarro Pablo, Pfang B, Delgado-Gómez David, Courtet P, Aroca F, Lopez-Castroman J, Artés-Rodríguez Antonio, Baca-García Enrique, MEmind study group User profiles of an electronic mental health tool for ecological momentary assessment: MEmind. Int J Methods Psychiatr Res. 2017 Mar;26(1):e1554. doi: 10.1002/mpr.1554.
    1. Firth J, Torous J, Yung AR. Ecological momentary assessment and beyond: The rising interest in e-mental health research. J Psychiatr Res. 2016 Sep;80:3–4. doi: 10.1016/j.jpsychires.2016.05.002.
    1. Onnela J, Rauch SL. Harnessing Smartphone-Based Digital Phenotyping to Enhance Behavioral and Mental Health. Neuropsychopharmacology. 2016 Jun;41(7):1691–6. doi: 10.1038/npp.2016.7.
    1. Insel TR. Digital Phenotyping: Technology for a New Science of Behavior. JAMA. 2017 Oct 03;318(13):1215–1216. doi: 10.1001/jama.2017.11295.
    1. Torous J, Onnela J, Keshavan M. New dimensions and new tools to realize the potential of RDoC: digital phenotyping via smartphones and connected devices. Transl Psychiatry. 2017 Mar 07;7(3):e1053. doi: 10.1038/tp.2017.25. doi: 10.1038/tp.2017.25.
    1. Palmier-Claus JE, Ainsworth J, Machin M, Barrowclough C, Dunn G, Barkus E, Rogers A, Wykes T, Kapur S, Buchan I, Salter E, Lewis SW. The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry. 2012 Oct 17;12:172. doi: 10.1186/1471-244X-12-172.
    1. Morgan C, Lappin J, Heslin M, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Doody GA, Dazzan P. Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychol. Med. 2014 Feb 26;44(13):2713–2726. doi: 10.1017/s0033291714000282.
    1. Hjorthøj Carsten, Stürup Anne Emilie, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017 Apr;4(4):295–301. doi: 10.1016/S2215-0366(17)30078-0.
    1. van der Krieke Lian, Wunderink L, Emerencia AC, de Jonge Peter, Sytema S. E-mental health self-management for psychotic disorders: state of the art and future perspectives. Psychiatr Serv. 2014 Jan 01;65(1):33–49. doi: 10.1176/appi.ps.201300050.
    1. Lysaker PH, Pattison ML, Leonhardt BL, Phelps S, Vohs JL. Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatry. 2018 Feb;17(1):12–23. doi: 10.1002/wps.20508. doi: 10.1002/wps.20508.
    1. Firth J, Cotter J, Torous J, Bucci S, Firth JA, Yung AR. Mobile Phone Ownership and Endorsement of "mHealth" Among People With Psychosis: A Meta-analysis of Cross-sectional Studies. Schizophr Bull. 2016 Mar;42(2):448–55. doi: 10.1093/schbul/sbv132.
    1. Johnson EI, Grondin O, Barrault M, Faytout M, Helbig S, Husky M, Granholm EL, Loh C, Nadeau L, Wittchen H, Swendsen J. Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study of acceptability, compliance, and reactivity. Int J Methods Psychiatr Res. 2009;18(1):48–57. doi: 10.1002/mpr.276.
    1. Firth J, Torous J. Smartphone Apps for Schizophrenia: A Systematic Review. JMIR Mhealth Uhealth. 2015 Nov 06;3(4):e102. doi: 10.2196/mhealth.4930.
    1. Granholm E, Loh C, Swendsen J. Feasibility and validity of computerized ecological momentary assessment in schizophrenia. Schizophr Bull. 2008 May;34(3):507–14. doi: 10.1093/schbul/sbm113.
    1. Moitra E, Gaudiano BA, Davis CH, Ben-Zeev D. Feasibility and acceptability of post-hospitalization ecological momentary assessment in patients with psychotic-spectrum disorders. Compr Psychiatry. 2017 Apr;74:204–213. doi: 10.1016/j.comppsych.2017.01.018.
    1. Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophr Bull. 2012 May;38(3):414–25. doi: 10.1093/schbul/sbr155.
    1. Niendam TA, Tully LM, Iosif A, Kumar D, Nye KE, Denton JC, Zakskorn LN, Fedechko TL, Pierce KM. Enhancing early psychosis treatment using smartphone technology: A longitudinal feasibility and validity study. J Psychiatr Res. 2018 Jan;96:239–246. doi: 10.1016/j.jpsychires.2017.10.017.
    1. Bell IH, Lim MH, Rossell SL, Thomas N. Ecological Momentary Assessment and Intervention in the Treatment of Psychotic Disorders: A Systematic Review. Psychiatr Serv. 2017 Nov 01;68(11):1172–1181. doi: 10.1176/appi.ps.201600523.
    1. Shin S, Yeom C, Shin C, Shin J, Jeong JH, Shin JU, Lee YR. Activity monitoring using a mHealth device and correlations with psychopathology in patients with chronic schizophrenia. Psychiatry Res. 2016 Dec 30;246:712–718. doi: 10.1016/j.psychres.2016.10.059.
    1. Seppälä Jussi, De Vita I, Jämsä Timo, Miettunen J, Isohanni M, Rubinstein K, Feldman Y, Grasa E, Corripio I, Berdun J, D'Amico E, M-RESIST Group. Bulgheroni M. Mobile Phone and Wearable Sensor-Based mHealth Approaches for Psychiatric Disorders and Symptoms: Systematic Review. JMIR Ment Health. 2019 Feb 20;6(2):e9819. doi: 10.2196/mental.9819.
    1. So SH, Peters ER, Swendsen J, Garety PA, Kapur S. Detecting improvements in acute psychotic symptoms using experience sampling methodology. Psychiatry Res. 2013 Nov 30;210(1):82–8. doi: 10.1016/j.psychres.2013.05.010.
    1. Staples P, Torous J, Barnett I, Carlson K, Sandoval L, Keshavan M, Onnela J. A comparison of passive and active estimates of sleep in a cohort with schizophrenia. NPJ Schizophr. 2017 Oct 16;3(1):37. doi: 10.1038/s41537-017-0038-0. doi: 10.1038/s41537-017-0038-0.
    1. Cella M, Okruszek. Lawrence M, Zarlenga V, He Z, Wykes T. Using wearable technology to detect the autonomic signature of illness severity in schizophrenia. Schizophr Res. 2018 May;195:537–542. doi: 10.1016/j.schres.2017.09.028.
    1. Cho H, Gonzalez R, Lavaysse LM, Pence S, Fulford D, Gard DE. Do people with schizophrenia experience more negative emotion and less positive emotion in their daily lives? A meta-analysis of experience sampling studies. Schizophr Res. 2017 May;183:49–55. doi: 10.1016/j.schres.2016.11.016.
    1. Mote J, Fulford D. Ecological momentary assessment of everyday social experiences of people with schizophrenia: A systematic review. Schizophr Res. 2020 Feb;216:56–68. doi: 10.1016/j.schres.2019.10.021.
    1. Granholm E, Holden JL, Mikhael T, Link PC, Swendsen J, Depp C, Moore RC, Harvey PD. What Do People With Schizophrenia Do All Day? Ecological Momentary Assessment of Real-World Functioning in Schizophrenia. Schizophr Bull. 2020 Feb 26;46(2):242–251. doi: 10.1093/schbul/sbz070.
    1. Reilly T, Mechelli A, McGuire P, Fusar-Poli P, Uhlhaas PJ. E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry. JMIR Ment Health. 2019 Oct 03;6(10):e14581. doi: 10.2196/14581.
    1. Barnett I, Torous J, Staples P, Sandoval L, Keshavan M, Onnela J. Relapse prediction in schizophrenia through digital phenotyping: a pilot study. Neuropsychopharmacology. 2018 Jul;43(8):1660–1666. doi: 10.1038/s41386-018-0030-z.
    1. Depp C, Mausbach B, Granholm E, Cardenas V, Ben-Zeev D, Patterson T, Lebowitz B, Jeste D. Mobile Interventions for Severe Mental Illness: Design and Preliminary Data From Three Approaches. The Journal of Nervous and Mental Disease Internet 2010 Oct. 2010 Oct 01;:715–721. doi: 10.1097/nmd.0b013e3181f49ea3.
    1. Wellness tracker. MeMind. [2021-07-07]. .
    1. Porras-Segovia A, Molina-Madueño Rosa María, Berrouiguet S, López-Castroman Jorge, Barrigón Maria Luisa, Pérez-Rodríguez María Sandra, Marco JH, Díaz-Oliván Isaac, de León Santiago, Courtet P, Artés-Rodríguez Antonio, Baca-García Enrique. Smartphone-based ecological momentary assessment (EMA) in psychiatric patients and student controls: A real-world feasibility study. J Affect Disord. 2020 Sep 01;274:733–741. doi: 10.1016/j.jad.2020.05.067.
    1. Lopez-Morinigo J, Ruiz-Ruano VG, Martínez Adela Sánchez Escribano, Estévez María Luisa Barrigón, Mata-Iturralde L, Muñoz-Lorenzo Laura, Sánchez-Alonso Sergio, Artés-Rodríguez Antonio, David AS, Baca-García Enrique. Study protocol of a randomised clinical trial testing whether metacognitive training can improve insight and clinical outcomes in schizophrenia. BMC Psychiatry. 2020 Jan 29;20(1):30. doi: 10.1186/s12888-020-2431-x.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–33;quiz 34.
    1. Wechsler D. The psychometric tradition: Developing the wechsler adult intelligence scale. Contemporary Educational Psychology. 1981 Apr;6(2):82–85. doi: 10.1016/0361-476x(81)90035-7.
    1. Berrouiguet S, Ramírez David, Barrigón María Luisa, Moreno-Muñoz Pablo, Carmona Camacho R, Baca-García Enrique, Artés-Rodríguez Antonio. Combining Continuous Smartphone Native Sensors Data Capture and Unsupervised Data Mining Techniques for Behavioral Changes Detection: A Case Series of the Evidence-Based Behavior (eB2) Study. JMIR Mhealth Uhealth. 2018 Dec 10;6(12):e197. doi: 10.2196/mhealth.9472.
    1. Evidence-Based Behavior. [2021-07-07]. .
    1. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470–84. doi: 10.1093/schbul/8.3.470.
    1. Reitan RM. Validity Of The Trail Making Test As An Indicator Of Organic Brain Damage. PMS. 1958 Dec;8(7):271. doi: 10.2466/pms.8.7.271-276.
    1. Peralta V, Cuesta MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994 Jul;53(1):31–40. doi: 10.1016/0165-1781(94)90093-0.
    1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76. doi: 10.1093/schbul/13.2.261.
    1. Soriano-Barceló J. Insight assessment in psychosis and psychopathological correlates: validation of the Spanish version of the Schedule for Assessment of Insight - Expanded Version. European Journal of Psychiatry. 2016. Jan 15, [2021-07-07]. .
    1. Blackwell B. Treatment Compliance and the Therapeutic Alliance. [2021-07-07]. .
    1. Brett-Jones J, Garety P, Hemsley D. Measuring delusional experiences: a method and its application. Br J Clin Psychol. 1987 Nov;26(4):257–65. doi: 10.1111/j.2044-8260.1987.tb01359.x.
    1. Gutiérrez-Zotes José A, Valero J, Cortés María J, Labad A, Ochoa S, Ahuir M, Carlson J, Bernardo M, Cañizares Silvia, Escartin G, Cañete José, Gallo P, Salamero M. Spanish adaptation of the Beck Cognitive Insight Scale (BCIS) for schizophrenia. Actas Esp Psiquiatr. 2012;40(1):2–9.
    1. Beck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr Res. 2004 Jun 01;68(2-3):319–29. doi: 10.1016/S0920-9964(03)00189-0.
    1. Corcoran R, Mercer G, Frith CD. Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia. Schizophr Res. 1995 Sep;17(1):5–13. doi: 10.1016/0920-9964(95)00024-g.
    1. Gil D, Fernández-Modamio Mar, Bengochea R, Arrieta M. [Adaptation of the Hinting Task theory of the mind test to Spanish] Rev Psiquiatr Salud Ment. 2012;5(2):79–88. doi: 10.1016/j.rpsm.2011.11.004.
    1. Baron-Cohen S, Wheelwright S, Jolliffe AT. Is There a "Language of the Eyes"? Evidence from Normal Adults, and Adults with Autism or Asperger Syndrome. Visual Cognition. 1997 Sep;4(3):311–331. doi: 10.1080/713756761.
    1. Ainsworth J, Palmier-Claus JE, Machin M, Barrowclough C, Dunn G, Rogers A, Buchan I, Barkus E, Kapur S, Wykes T, Hopkins RS, Lewis S. A comparison of two delivery modalities of a mobile phone-based assessment for serious mental illness: native smartphone application vs text-messaging only implementations. J Med Internet Res. 2013 Apr 05;15(4):e60. doi: 10.2196/jmir.2328.
    1. Ben-Zeev D, Brenner CJ, Begale M, Duffecy J, Mohr DC, Mueser KT. Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull. 2014 Nov;40(6):1244–53. doi: 10.1093/schbul/sbu033.
    1. Ashcroft RE. Personal financial incentives in health promotion: where do they fit in an ethic of autonomy? Health Expect. 2011 Jun;14(2):191–200. doi: 10.1111/j.1369-7625.2011.00664.x. doi: 10.1111/j.1369-7625.2011.00664.x.
    1. Groth SW. Honorarium or coercion: use of incentives for participants in clinical research. J N Y State Nurses Assoc. 2010;41(1):11–3; quiz 22.
    1. Singer E, Couper MP. Do incentives exert undue influence on survey participation? Experimental evidence. J Empir Res Hum Res Ethics. 2008 Sep;3(3):49–56. doi: 10.1525/jer.2008.3.3.49.
    1. David AS. Insight and psychosis: the next 30 years. Br J Psychiatry. 2020 Sep;217(3):521–523. doi: 10.1192/bjp.2019.217.
    1. Meyer N, Kerz M, Folarin A, Joyce DW, Jackson R, Karr C, Dobson R, MacCabe J. Capturing Rest-Activity Profiles in Schizophrenia Using Wearable and Mobile Technologies: Development, Implementation, Feasibility, and Acceptability of a Remote Monitoring Platform. JMIR Mhealth Uhealth. 2018 Oct 30;6(10):e188. doi: 10.2196/mhealth.8292.
    1. Kimhy D, Myin-Germeys I, Palmier-Claus J, Swendsen J. Mobile assessment guide for research in schizophrenia and severe mental disorders. Schizophr Bull. 2012 May;38(3):386–95. doi: 10.1093/schbul/sbr186.
    1. Kumar D, Tully LM, Iosif A, Zakskorn LN, Nye KE, Zia A, Niendam TA. A Mobile Health Platform for Clinical Monitoring in Early Psychosis: Implementation in Community-Based Outpatient Early Psychosis Care. JMIR Ment Health. 2018 Feb 27;5(1):e15. doi: 10.2196/mental.8551.
    1. Edwards CJ, Cella M, Emsley R, Tarrier N, Wykes THM. Exploring the relationship between the anticipation and experience of pleasure in people with schizophrenia: An experience sampling study. Schizophr Res. 2018 Dec;202:72–79. doi: 10.1016/j.schres.2018.06.040.
    1. David AS. Insight and psychosis. Br J Psychiatry. 1990 Jun;156:798–808. doi: 10.1192/bjp.156.6.798.
    1. Moritz S, Woodward T. Metacognitive training for schizophrenia patients (MCT): A pilot study on feasibility, treatment adherence, and subjective efficacy. German Journal of Psychiatry. 2007. Aug 01, [2021-07-07]. .
    1. Arango C. Lessons Learned From the Coronavirus Health Crisis in Madrid, Spain: How COVID-19 Has Changed Our Lives in the Last 2 Weeks. Biol Psychiatry. 2020 Oct 01;88(7):e33–e34. doi: 10.1016/j.biopsych.2020.04.003.
    1. Kawohl W, Nordt C. COVID-19, unemployment, and suicide. Lancet Psychiatry. 2020 May;7(5):389–390. doi: 10.1016/S2215-0366(20)30141-3.
    1. Oyesanya M, Lopez-Morinigo J, Dutta R. Systematic review of suicide in economic recession. World J Psychiatry. 2015 Jun 22;5(2):243–54. doi: 10.5498/wjp.v5.i2.243.
    1. Holmes EA, O'Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I, Ford T, John A, Kabir T, King K, Madan I, Michie S, Przybylski AK, Shafran R, Sweeney A, Worthman CM, Yardley L, Cowan K, Cope C, Hotopf M, Bullmore E. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020 Jun;7(6):547–560. doi: 10.1016/S2215-0366(20)30168-1.
    1. Torous J, Wykes T. Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth. JAMA Psychiatry. 2020 Dec 01;77(12):1205–1206. doi: 10.1001/jamapsychiatry.2020.1640.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel